Boothbay Fund Management, LLC Capricor Therapeutics, Inc. Transaction History
Boothbay Fund Management, LLC
- $3.27 Billion
- Q4 2024
A detailed history of Boothbay Fund Management, LLC transactions in Capricor Therapeutics, Inc. stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 87,700 shares of CAPR stock, worth $1.15 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
87,700
Previous 87,700
-0.0%
Holding current value
$1.15 Million
Previous $1.33 Million
8.93%
% of portfolio
0.04%
Previous 0.04%
Shares
1 transactions
Others Institutions Holding CAPR
# of Institutions
133Shares Held
16MCall Options Held
1.73MPut Options Held
1.71M-
Vanguard Group Inc Valley Forge, PA2.28MShares$29.9 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA2.25MShares$29.5 Million0.17% of portfolio
-
State Street Corp Boston, MA2.21MShares$29 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$21.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA879KShares$11.5 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $320M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...